Immunity 2013-11-14

Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.

Noah W Palm, Rachel K Rosenstein, Shuang Yu, Dominik D Schenten, Esther Florsheim, Ruslan Medzhitov

Index: Immunity 39(5) , 976-85, (2013)

Full Text: HTML

Abstract

Venoms consist of toxic components that are delivered to their victims via bites or stings. Venoms also represent a major class of allergens in humans. Phospholipase A2 (PLA2) is a conserved component of venoms from multiple species and is the major allergen in bee venom. Here we examined how bee venom PLA2 is sensed by the innate immune system and induces a type 2 immune response in mice. We found that bee venom PLA2 induced a T helper type 2 (Th2) cell-type response and group 2 innate lymphoid cell activation via the enzymatic cleavage of membrane phospholipids and release of interleukin-33. Furthermore, we showed that the IgE response to PLA2 could protect mice from future challenge with a near-lethal dose of PLA2. These data suggest that the innate immune system can detect the activity of a conserved component of venoms and induce a protective immune response against a venom toxin. Copyright © 2013 Elsevier Inc. All rights reserved.


Related Compounds

Related Articles:

Inhibition of TRPM7 channels reduces degranulation and release of cytokines in rat bone marrow-derived mast cells.

2014-01-01

[Int. J. Mol. Sci. 15(7) , 11817-31, (2014)]

Cytokine responses to egg protein in previously allergic children who developed tolerance naturally.

2014-12-01

[Ann. Allergy Asthma Immunol. 113(6) , 667-670.e4, (2014)]

Lipopolysaccharides facilitate colonic motor alterations associated to the sensitization to a luminal antigen in rats.

2015-03-30

[J. Neurogastroenterol. Motil. 21(2) , 222-35, (2015)]

Electrodynamic pressure modulation of protein stability in cosolvents.

2013-11-19

[Biochemistry 52(46) , 8363-73, (2013)]

Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein.

2015-03-01

[Mol. Immunol. 64(1) , 36-45, (2015)]

More Articles...